Ceapro Inc. (CVE:CZO – Get Free Report) was down 11.8% during trading on Tuesday. The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares changed hands during trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The company’s fifty day simple moving average is C$0.22 and its two-hundred day simple moving average is C$0.23. The company has a market capitalization of C$688,880.00, a price-to-earnings ratio of -2.83 and a beta of 1.38. The company has a debt-to-equity ratio of 8.07, a quick ratio of 18.88 and a current ratio of 8.54.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Recommended Stories
- Five stocks we like better than Ceapro
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
